WAY-629

WAY-629
Names
IUPAC name
1,2,3,4,8,9,10,11-Octahydro[1,4]diazepino[6,7,1-jk]carbazole
Identifiers
CAS Number
  • 57756-44-2 checkY
3D model (JSmol)
  • Interactive image
ChEBI
  • CHEBI:92969
ChEMBL
  • ChEMBL258465
ChemSpider
  • 5037189
PubChem CID
  • 6604933
UNII
  • S3TQZ8FAS2 checkY
CompTox Dashboard (EPA)
  • DTXSID0043890 Edit this at Wikidata
InChI
  • InChI=1S/C15H18N2/c1-2-7-14-12(5-1)13-6-3-4-11-10-16-8-9-17(14)15(11)13/h3-4,6,16H,1-2,5,7-10H2
    Key: OIGHTPDWPMLMGT-UHFFFAOYSA-N
  • InChI=1/C15H18N2/c1-2-7-14-12(5-1)13-6-3-4-11-10-16-8-9-17(14)15(11)13/h3-4,6,16H,1-2,5,7-10H2
    Key: OIGHTPDWPMLMGT-UHFFFAOYAM
  • C1CCC2=C(C1)C3=CC=CC4=C3N2CCNC4
Properties
Chemical formula
C15H18N2
Molar mass 226.32 g mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references
Chemical compound

WAY-629 is a 5-HT2C agonist that reduces feeding behavior when administered to rats. It was used as a starting point for developing more potent and selective 5-HT2C agonists aimed at treating obesity.[1]

References

  1. ^ Sabb, AL (May 2004). "Cycloalkyl[b][1,4]benzodiazepinoindoles are agonists at the human 5-HT2C receptor". Bioorganic & Medicinal Chemistry Letters. 14 (10): 2603–7. doi:10.1016/j.bmcl.2004.02.100. PMID 15109661.
  • v
  • t
  • e
Antiobesity agents/Anorectics (A08)
Stimulants
Amphetamines and
phenethylamines
Adrenergic agonists
Other
Cannabinoid
antagonistsGLP-1, GIP, and / or
glucagon agonistsDACRAs5-HT2C
receptor agonistsAbsorption inhibitorsUncouplersOthers
  • v
  • t
  • e
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
  • See also: Receptor/signaling modulators
  • Adrenergics
  • Dopaminergics
  • Melatonergics
  • Monoamine reuptake inhibitors and releasing agents
  • Monoamine metabolism modulators
  • Monoamine neurotoxins